Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Keyfarm is a South Korean pharmaceutical and healthcare company established in 2007, headquartered in Seoul. The company specializes in the development, manufacturing, and distribution of ethical drugs (ETC), over-the-counter (OTC) medications, and health functional foods. Keyfarm's R&D efforts are primarily focused on Incrementally Modified Drugs (IMDs) and high-value generics within the cardiovascular, gastrointestinal, and musculoskeletal therapeutic areas. The company is well-regarded in the Korean market for its specialized supplement lines, including the Key-D and Key-Cal brands, which target bone health and nutritional deficiencies. Keyfarm operates a dedicated research institute and manufacturing facility in Hwaseong, Gyeonggi-do, ensuring integrated quality control and product innovation.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Keyfarm.